Results for “”

Entry Author Date Location
IgGenix Grabs $10M to Advance Antibody Treatments for Allergies 08/05/20 San Francisco
As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up 08/05/20 New York
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology 08/05/20 Boston
Still Stuck on Adhesion Issues, FDA Rejects DBV’s Peanut Allergy Patch 08/04/20 National
CymaBay PBC Drug Hits Phase 3 Goals With Signs of Side Effect Advantage 08/04/20 San Francisco
AbbVie Walks From Voyager R&D Pact Spanning Alzheimer’s, Parkinson’s 08/04/20 Boston
MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T 08/03/20 Europe
Kymera Therapeutics Unveils IPO Pitch for Protein Degradation 07/31/20 Boston
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Novartis Pays $75M to Get Hands on Sangamo’s Zinc Fingers for Drug R&D 07/30/20 San Francisco
AlloVir’s IPO Raises $276M to Test Cell Therapies in Transplant Patients 07/30/20 Boston
Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort 07/29/20 San Diego
Roche Pays $120M for Rights to UCB’s Tau-Targeting Alzheimer’s Drug 07/29/20 Europe
2020 National Xconomy Awards Finalists Announced 07/29/20 National
Omega Therapeutics Lands $85M to Tap Into “Control Room” of Biology 07/29/20 Boston
Nura Bio Debuts With $73M and Plan to Develop “Neuroprotective” Drugs 07/29/20 San Francisco
Thrive Adds $257M, Plans Pivotal Trial of Early Cancer Detection Test 07/29/20 National
Pfizer, BioNTech Choose Full Spike Protein for Pivotal Vaccine Test 07/28/20 New York
Telehealth Firm AristaMD Adds $24M to Link Primary Docs With Specialists 07/27/20 San Diego
AstraZeneca to Pay $1B to Team Up With Daiichi Sankyo Again in Cancer 07/27/20 Europe
Clinical Trial Diversity Isn’t Just a Moral Issue–It’s a Scientific Imperative 07/27/20 National
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma 07/24/20 San Francisco
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
FDA Lifts CymaBay Drug Hold, Tests to Resume in Rare Liver Disease PBC 07/23/20 San Francisco
Jazz Pharma Gets FDA Nod for New Drug to Treat Narcolepsy Symptoms 07/22/20 Europe
Vesigen Nabs $28M to Wrap “ARMMS” Around Large Molecule Drug Delivery 07/22/20 Boston
Seer Raises $55M to Commercialize Tools to Analyze the Proteome 07/22/20 San Francisco
Olema Adds $54M to Start Human Tests of Breast Cancer Drug Candidate 07/22/20 San Francisco
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs 07/21/20 New York
Page 1 of 1971 next page »